RP Management’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-31,841,394
| Closed | -$46.8M | – | 4 |
|
|
2022
Q2 | $46.8M | Buy |
31,841,394
+8,060
| +0% | +$11.8K | 18.49% | 2 |
|
|
2022
Q1 | $47.8M | Buy |
31,833,334
+22,666,667
| +247% | +$34M | 19.42% | 3 |
|
|
2021
Q4 | $22.9M | Hold |
9,166,667
| – | – | 9.59% | 3 |
|
|
2021
Q3 | $46.9M | Hold |
9,166,667
| – | – | 21.9% | 2 |
|
|
2021
Q2 | $76.2M | Hold |
9,166,667
| – | – | 37.14% | 2 |
|
|
2021
Q1 | $79.8M | Hold |
9,166,667
| – | – | 29.97% | 2 |
|
|
2020
Q4 | $99.6M | Hold |
9,166,667
| – | – | 30.54% | 2 |
|
|
2020
Q3 | $109M | Hold |
9,166,667
| – | – | 16.39% | 3 |
|
|
2020
Q2 | $147M | Hold |
9,166,667
| – | – | 28.46% | 3 |
|
|
2020
Q1 | $142M | Buy |
9,166,667
+2,500,000
| +37% | +$38.8M | 44.14% | 1 |
|
|
2019
Q4 | $164M | Buy |
+6,666,667
| New | +$164M | 37.08% | 1 |
|